Poland· PL-100305831
Amyvid
A florbetapir (18f) product containing florbetapirum (18f), registered in Poland by Eli Lilly Nederland B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Florbetapir (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09AX05 (florbetapir (18f)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Florbetapir (18f) · ATC V09AX05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Florbetapirum (18F)
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Poland (PL)
- ATC code
- V09AX05
- ATC class
- Florbetapir (18F)
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991093396
- gtin05909991093402
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09AX05
Florbetapir (18f), as other registers publish it.
- DenmarkAmyvidEli Lilly Netherland B.V.
- FinlandAmyvidEli Lilly Nederland B.V.
- DenmarkAmyvidEli Lilly Netherland B.V.
- FinlandAmyvidEli Lilly Nederland B.V.
- PolandAmyvidEli Lilly Nederland B.V.
- IcelandAMYViDEli Lilly Nederland B.V.*
- IcelandAMYViDEli Lilly Nederland B.V.*
- CzechiaAMYVIDEli Lilly Nederland B.V., Utrecht
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a428c3c5-8146-451e-8242-dd7c5167eb17 GET /v1/drugs/a428c3c5-8146-451e-8242-dd7c5167eb17?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "800 MBq/ml",
"packaging": "05909991093396 ¦ Rpz ¦ EU/1/12/805/001 ¦ 87331\n1 fiol. 1 ml - 10 ml roztworu\n05909991093402 ¦ Rpz ¦ EU/1/12/805/002 ¦ 87332\n1 fiol. 1 ml - 15 ml roztworu",
"substance": "Florbetapirum (18F) 800 MBq/ml",
"common_name": "Florbetapirum (18F)",
"pl_product_id": "100305831",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about florbetapir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.